샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794602

세계의 환자 생성 건강 데이터 시장

Patient Generated Health Data
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 277 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

환자 생성 건강 데이터 세계 시장은 2030년까지 75억 달러에 달할 전망

2024년에 52억 달러로 추정되는 환자 생성 건강 데이터 세계 시장은 2024년부터 2030년까지 CAGR 6.1%로 성장하여 2030년에는 75억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 피트니스 및 웰니스 데이터는 CAGR 8.0%를 기록하며 분석 기간 종료시에는 33억 달러에 달할 것으로 예측됩니다. 질병 관리 데이터 분야의 성장률은 분석 기간 동안 CAGR 4.5%로 추정됩니다.

미국 시장은 14억 달러, 중국은 CAGR 10.0%로 성장할 것으로 예측

미국의 환자 생성 건강 데이터 시장은 2024년에 14억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 16억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 10.0%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.9%와 6.1%로 예측됩니다. 유럽에서는 독일이 CAGR 4.0%로 성장할 것으로 예측됩니다.

세계의 환자 생성 건강 데이터 시장 - 주요 동향과 촉진요인 정리

환자 생성 건강 데이터란 무엇이며, 왜 임상적 의사결정에 유용한가?

환자 생성 건강 데이터(PGHD)는 웨어러블, 모바일 앱, 자가보고 입력 등 기존 임상 현장 외에서 개인이 생성, 기록, 수집한 건강 관련 데이터를 말합니다. 이 데이터에는 증상, 생활습관 행동, 생체 측정값, 치료 순응도, 삶의 질 지표에 대한 정보가 포함됩니다. PGHD는 병원 방문이나 검사를 통해 얻은 데이터와 달리, 환자의 일상적인 건강 상태에 대한 지속적인 실시간 인사이트를 제공합니다.

PGHD의 사용은 특히 만성질환 관리와 예방의학에서 환자 모니터링과 개별화된 치료 제공에 변화를 가져오고 있습니다. PGHD는 임상과 임상 사이의 중요한 격차를 해소하고 임상의에게 환자의 경과와 행동에 대한 보다 종합적인 시각을 제공합니다. 헬스케어가 결과 기반 모델로 전환되고 있는 가운데, PGHD를 케어 플랜에 포함시킴으로써 반응성, 조기 개입, 환자와 의료진 간의 협력이 개선되고 있습니다.

PGHD의 수집과 사용을 지원하는 장치, 플랫폼, 표준은 어떻게 진화하고 있는가?

기술의 발전으로 PGHD의 범위, 정확도, 사용 편의성이 향상되고 있습니다. 웨어러블 기기는 현재 심박수, 포도당 수치, 수면 패턴, 활동량 등 다양한 매개변수를 의료 수준의 정확도로 모니터링하고 있습니다. 스마트폰 애플리케이션을 통해 사용자는 약물 섭취량, 기분, 식습관 등을 추적할 수 있습니다. 음성 인식 도구와 스마트홈 디바이스도 환자가 사용하기 쉬운 형태로 수동적인 데이터 수집에 기여하고 있습니다.

PGHD를 임상적으로 적합하게 만들기 위해 이 데이터를 구조화되고 해석 가능한 형식으로 전자의무기록에 통합하기 위한 플랫폼이 개발되고 있습니다. 표준화된 API와 데이터 거버넌스 프레임워크를 통해 데이터 보안, 상호운용성, 동의 관리가 개선되고 있습니다. 임상 알고리즘과 대시보드는 의사가 PGHD를 필터링, 우선순위화, 시각화하여 원시 데이터에 압도당하지 않고 의미 있는 변화에 대응할 수 있도록 설계되었습니다.

PGHD의 채택이 확대되고 있는 곳은 어디이며, 어떤 사용사례가 애플리케이션을 주도하고 있는가?

PGHD는 헬스케어 시스템, 웰니스 프로그램, 원격 환자 모니터링 서비스, 임상 연구 등에 적용이 확대되고 있습니다. 북미와 유럽은 환자 주도형 데이터 활용을 위한 인프라 준비와 규제적 지원에서 선두를 달리고 있습니다. 아시아태평양은 웨어러블과 건강 앱의 가격이 저렴해지고 다양한 계층이 이용할 수 있게 되면서 빠르게 추격하고 있습니다.

사용 사례는 당뇨병, 심혈관질환, 정신건강, 종양학, 호흡기질환 등 다양한 질환으로 확대되고 있습니다. 원격 환자 모니터링 프로그램은 PGHD에 의존하여 조기 경고 징후를 감지하고 입원을 줄이기 위해 PGHD에 의존하고 있습니다. 임상시험에서 환자 보고 결과와 실시간 바이오메트릭을 통해 데이터의 정확성과 참여자 유지율을 향상시키고 있습니다. 보험사들도 PGHD를 활용하여 웰니스 인센티브를 조정하고 위험 프로파일을 보다 정확하게 평가하고 있습니다.

환자 생성 건강 데이터 시장의 성장은 몇 가지 요인에 의해 이루어집니다.

환자 생성 건강 데이터 시장의 성장은 웨어러블 기술 채택 증가, 맞춤형 의료에 대한 관심 증가, 지속적인 건강 모니터링에 대한 수요 증가 등의 요인으로 인해 발생할 수 있습니다. 센서의 소형화, 모바일 연결성, 건강 추적 알고리즘의 발전으로 다양한 계층에서 신뢰할 수 있고 사용하기 쉬운 데이터 수집이 가능해졌습니다.

원격진료에 대한 환급과 디지털 의료 기록의 통합을 지원하는 규제 프레임워크는 의료 서비스 제공자가 일상적인 진료 관리에 PGHD를 포함하도록 장려하고 있습니다. 만성질환 모니터링, 퇴원 후 관리, 웰니스 트래킹은 PGHD의 실용성이 높은 응용 분야를 창출하고 있습니다. 환자들의 인식과 자기관리 행동의 향상으로 데이터가 더욱 풍부해지고 있으며, PGHD는 집단 건강 분석, 위험 계층화, 사전 예방적 치료 제공 모델에 중요한 인풋으로 작용하고 있습니다.

부문

데이터 유형(피트니스 및 웰니스 데이터, 질병 관리 데이터, 원격 모니터링 데이터, 기타 데이터 유형), 최종사용자(병원 및 클리닉 최종사용자, 연구 센터 최종사용자, 의료비 지불자 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • AliveCor Inc.
  • Allscripts Healthcare Solutions
  • Apple Inc.
  • Athenahealth Inc.
  • Cerner Corporation
  • Dexcom Inc.
  • Epic Systems Corporation
  • Fitbit Inc.
  • HealthMine Inc.
  • Livongo Health(now part of Teladoc)
  • Medidata Solutions
  • Medtronic plc
  • Noom Inc.
  • Omada Health Inc.
  • PatientLikeMe
  • Propeller Health
  • WellDoc Inc.
  • Luscii(Omron)
  • Athelas
  • Kwido

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Patient Generated Health Data Market to Reach US$7.5 Billion by 2030

The global market for Patient Generated Health Data estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Fitness & Wellness Data, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Disease Management Data segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.0% CAGR

The Patient Generated Health Data market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Patient Generated Health Data Market - Key Trends & Drivers Summarized

What Is Patient Generated Health Data and Why Is It Valuable in Clinical Decision Making?

Patient generated health data (PGHD) refers to health-related data created, recorded, or gathered by individuals outside traditional clinical settings, often through wearables, mobile apps, or self-reported inputs. This data includes information on symptoms, lifestyle behaviors, biometric readings, treatment adherence, and quality of life metrics. Unlike data captured during hospital visits or lab tests, PGHD provides continuous, real-time insights into a patient’s day-to-day health status.

The use of PGHD is transforming patient monitoring and personalized care delivery, particularly in chronic disease management and preventive health. It fills important gaps between clinical encounters, offering clinicians a more holistic view of patient progress and behavior. As healthcare moves toward outcome-based models, the inclusion of PGHD in care planning is improving responsiveness, early intervention, and patient-provider collaboration.

How Are Devices, Platforms, and Standards Evolving to Support PGHD Collection and Use?

Technological advancements are enhancing the scope, accuracy, and usability of PGHD. Wearable devices now monitor a wide range of parameters including heart rate, glucose levels, sleep patterns, and activity levels with medical-grade precision. Smartphone applications are allowing users to track medication intake, mood, and dietary habits. Voice recognition tools and smart home devices are also contributing to passive data capture in patient-friendly formats.

To make PGHD clinically relevant, platforms are being developed to integrate this data into electronic health records in structured, interpretable formats. Standardized APIs and data governance frameworks are improving data security, interoperability, and consent management. Clinical algorithms and dashboards are being designed to filter, prioritize, and visualize PGHD for physicians, enabling them to respond to meaningful changes without being overwhelmed by raw data.

Where Is PGHD Adoption Expanding and Which Use Cases Are Leading Application?

PGHD adoption is growing across healthcare systems, wellness programs, remote patient monitoring services, and clinical research. North America and Europe are leading in infrastructure readiness and regulatory support for patient-driven data use. Asia-Pacific is catching up rapidly as wearables and health apps become more affordable and accessible to broad segments of the population.

Use cases are expanding across conditions such as diabetes, cardiovascular disease, mental health, oncology, and respiratory illness. Remote patient monitoring programs rely on PGHD to detect early warning signs and reduce hospital admissions. In clinical trials, patient-reported outcomes and real-time biometrics are improving data accuracy and participant retention. Insurance providers are also utilizing PGHD to tailor wellness incentives and assess risk profiles with greater precision.

Growth in the Patient Generated Health Data market is driven by several factors…

Growth in the patient generated health data market is driven by factors such as rising adoption of wearable technologies, increasing focus on personalized medicine, and growing demand for continuous health monitoring. Advances in sensor miniaturization, mobile connectivity, and health tracking algorithms are enabling reliable, user-friendly data collection across varied demographics.

Regulatory frameworks supporting remote care reimbursement and digital health record integration are encouraging healthcare providers to include PGHD in routine care management. Chronic disease monitoring, post-discharge care, and wellness tracking are creating high-utility application areas for PGHD. Enhanced patient awareness and self-management behaviors are further contributing to data richness, making PGHD a key input for population health analytics, risk stratification, and proactive care delivery models.

SCOPE OF STUDY:

The report analyzes the Patient Generated Health Data market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Data Type (Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data, Other Data Types); End-Use (Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AliveCor Inc.
  • Allscripts Healthcare Solutions
  • Apple Inc.
  • Athenahealth Inc.
  • Cerner Corporation
  • Dexcom Inc.
  • Epic Systems Corporation
  • Fitbit Inc.
  • HealthMine Inc.
  • Livongo Health (now part of Teladoc)
  • Medidata Solutions
  • Medtronic plc
  • Noom Inc.
  • Omada Health Inc.
  • PatientLikeMe
  • Propeller Health
  • WellDoc Inc.
  • Luscii (Omron)
  • Athelas
  • Kwido

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Patient Generated Health Data - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized and Preventive Care Models Spurs Integration of Patient Generated Health Data (PGHD)
    • Expansion of Wearable Devices and Mobile Health Apps Strengthens Data Flow From Patients to Providers
    • Shift Toward Remote Monitoring and Home-Based Care Throws the Spotlight on Real-Time PGHD for Clinical Decision Support
    • Government and Payer Incentives for Chronic Disease Management Encourage Use of PGHD for Outcome-Based Care
    • Advancements in Interoperability and API Integration Improve EMR Compatibility With External Health Data Sources
    • Surge in Consumer Awareness and Digital Health Literacy Supports Active Health Tracking and Data Sharing Behavior
    • Growing Role of AI and Data Analytics Enables Derivation of Actionable Insights From Unstructured PGHD
    • Development of Condition-Specific Tracking Tools Enhances Monitoring of Diabetes, Cardiac Conditions, and Mental Health
    • Patient Empowerment Movements Promote Active Participation in Health Management Through Data Contribution
    • Concerns Over Data Accuracy and Standardization Encourage Investment in Structured Input Tools and Validation Algorithms
    • Integration With Population Health Platforms Enhances Cohort Monitoring and Predictive Modeling
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient Generated Health Data Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Patient Generated Health Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fitness & Wellness Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Fitness & Wellness Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Fitness & Wellness Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disease Management Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disease Management Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Disease Management Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Remote Monitoring Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Remote Monitoring Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Remote Monitoring Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Data Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Data Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Data Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Patient Generated Health Data by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Patient Generated Health Data by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Patient Generated Health Data by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Patient Generated Health Data by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제